Related Experiment Videos
[Retroperitoneal laparoscopic surgery and carcinogenic risk]
1Service d'Urologie, Hôpital Henri Mondor, 51, avenue du Maréchal de Lattre de Tassigny, 94010 Créteil. a.cicco@oreka.com
Summary
Retroperitoneal laparoscopy for malignant upper tract tumors shows no increased risk of metastasis or local recurrence. Recurrence-free survival rates are comparable to traditional surgery, supporting its use.
Area of Science:
- Urology
- Surgical Oncology
- Minimally Invasive Surgery
Context:
- Retroperitoneal laparoscopic surgery is increasingly used for malignant upper urinary tract tumors.
- Evaluating oncologic outcomes, including metastasis and recurrence, is crucial for patient management.
Purpose:
- To assess the incidence of trocar site metastasis, local recurrence, and distant metastases after retroperitoneal laparoscopic surgery for malignant tumors.
- To determine the recurrence-free survival rates for these procedures.
Summary:
- A retrospective review of 228 retroperitoneal laparoscopic operations (56 for malignant tumors) found no trocar site metastases.
- Local recurrence and distant metastases were observed in a small percentage of patients, with recurrence-free survival rates comparable to conventional surgery.
- Specific outcomes included 91% recurrence-free survival at 54 months for radical nephrectomies and 71% at 30 months for nephro-ureterectomies.
Impact:
- Retroperitoneal laparoscopy appears to be a safe and effective surgical option for malignant upper urinary tract tumors.
- The findings support the use of this minimally invasive approach without compromising oncologic control.